ACI HealthCare Limited, a subsidiary of ACI PLC, develops, manufactures and supplies high-quality generic pharmaceuticals for regulated and emerging markets. Built on internationally aligned quality systems, strong governance and scientific discipline, we support partners through formulation development, technology transfer, commercial- scale manufacturing and quality-assured contract manufacturing solutions.
ACI HealthCare Limited operates a modern pharmaceutical manufacturing facility designed to meet the stringent expectations of regulated international markets.
It serves as the strategic international interface for ACI HealthCare Limited, supporting market access, regulatory coordination, and business development activities in the United States.
ACI HealthCare Limited is committed to expanding beyond conventional market and operational limits to address evolving global healthcare needs. Our vision extends across geographies, technologies, and partnerships, enabling us to deliver accessible, quality medicines to diverse patient populations.
With a growing presence across the United States, Europe, Middle East & North Africa (MENA), Asia Pacific emerging markets, and Latin America (LATAM), we are continuously strengthening our global footprint. By combining scientific capability with strategic market insight, we explore new opportunities that enhance access, reliability, and long-term healthcare impact.
This forward-looking approach includes advancing into complex generics, future-ready delivery systems, and potential backward integration into APIs, while building strong collaborations across regulated and high-growth markets. Through innovation, scalability, and disciplined execution, we aim to move beyond boundaries creating sustainable value for healthcare systems, partners, and communities worldwide.
Our defining strength lies in delivering pharmaceutical solutions aligned with global standards, supported by stringent quality systems and a strong commitment to regulatory compliance, transparency, and integrity.
ACI HealthCare Limited delivers a portfolio of global-standard generic pharmaceutical products by integrating manufacturing excellence with regulatory standards and a strong commitment to the wellbeing of people across global markets. Our products are developed through a science- based, risk-managed and lifecycle-controlled approach, ensuring consistent performance and regulatory confidence across the markets we serve.
ACI HealthCare Limited's Azithromycin represents a key milestone in our commitment to delivering globally trusted, high-quality anti-infective medicines. Developed and manufactured under internationally compliant GMP standards, this product reflects our strong capability in producing essential therapies with consistent quality and reliability.
Our Azithromycin has achieved WHO Prequalification (WHO PQ), a globally recognized endorsement of quality, safety, and efficacy enabling participation in international procurement programs and supporting access to medicines in high-need regions.
Backed by validated manufacturing processes, advanced analytical controls, and ICH-aligned stability programs, the product ensures consistent performance, controlled impurity profiles, and reliable therapeutic outcomes. It is designed to meet the expectations of both regulated and emerging markets, supporting broad global distribution.
More Products
ACI HealthCare Limited's Othera (Esomeprazole Magnesium Trihydrate USP) exemplifies our dedication to producing high-quality gastrointestinal therapies for global markets. Manufactured in our state-of-the-art facility under stringent GMP standards, Othera delivers consistent efficacy and pharmaceutical integrity.
Othera is formulated as a delayed-release tablet, ensuring optimal bioavailability and targeted therapeutic action. It is designed for the treatment of gastroesophageal reflux disease (GERD), erosive esophagitis, and other acid-related disorders.
With robust stability data aligned to ICH guidelines and validated manufacturing processes, Othera meets the quality expectations of both regulated and emerging markets worldwide.
More Products
At the core of our manufacturing philosophy is an unwavering commitment to international quality, safety, and compliance. Our journey of excellence is marked by continuous validation from the world's most stringent regulatory authorities.
